Introduction
In order to access medical care, poor people may have to overcome various kinds of problems, including lack of appropriate health information, financial burden, health care system barriers, cultural and social barriers, psychological distress, and so on. Such problems can lead patients to delay treatment or improper health-seeking behaviors or even the decision to forego treatment.
Objectives of the study
The objectives of this study were:
To identify the different types of barriers poor patients affected by HIV/AIDS and diabetes encounter in accessing care and treatment.
To compare HIV/AIDS and diabetes patients' experiences in seeking treatment and care through the different stages, which can help us understand the complexity of the problems related to both the demandside and the supply-side system.
Analytical framework

Phase
Description of the phase code Types of problems 
Reliable source of information on diagnosis:
HIV/AIDS patients were more aware of facilities for testing, particularly at public health care facilities than diabetic patients No information disseminated, most diabetic patients relied more on other sources or methods of diagnosis, such as through peerpatients and traditional techniques Poor quality of health services in making accurate diagnoses and lack of trust in providers particularly those in the private sector led patients to have multiple diagnoses Stage 2: Barriers to accessing medical treatment
Knowledge and perception of curability of disease:
Majority of HIV/AIDS patients understand that HIV/AIDS could not be cured, whereas diabetic patients perceived that diabetes could be cured permanently, especially with traditional medicine or a combination of both modern and traditional medicines.
Institutional policy as barrier to medical treatment
The rationing strategy of Center of Hope and the policy of the MSF Takeo clinic to enroll only patients living in the coverage area, but these policies apply only for diabetes patients, not HIV/AIDS patients.
Since poor diabetic patients knew of only these two institutions providing free or cheap treatment of high quality, they would spend a great deal of resources and energy trying to get into the programs, like playing a game with very little chance of winning.
Stage 2: Barriers to accessing medical treatment (cont.)
Financial and opportunity costs as barriers to accessing treatment
Because of the limited availability of care and treatment for diabetes in the public health sector, diabetic patients often sought out treatment at private clinics or pharmacies, paying from out of pockets.
Paying for expensive medicine at private clinics out of pocket can be costly, leading households into poverty. As one patient stated: We diabetic patients tend to say that HIV/AIDS patients are lucky because they have an NGO helping them but for us we don't have any support; instead they charge us for medicine. Honestly, I wish I had AIDS more than diabetes.
(PLWD #6 at MSF clinic in Takeo.)
Stage 4: Life-style change as barriers in brining the disease under control
Most PLHA said that they had been informed by doctors about the possible side effects of the medication; emotional encouragement from doctors and counselors helped them to go on taking medicine despite the many side effects they experienced.
Perceptions and believe of the curability of chronic diseases influenced both health-seeking behavior and adherence to care and treatment.
I think AIDS cannot be cured but I can live longer with ARV. Now I have stopped using traditional medicine completely because the doctor told me not to take any other medicine without his advice, and also because I myself don't want to take it any more because it cannot cure the disease. (PLHA #8 at MSF Takeo.)
Understanding and adhering to food restrictions and physical exercise was a major factor in the ability of patients to bring their diabetes under control. 
Stage 4: Cost of medicine as barrier to adherence
In low-income countries most patients simply cannot afford to pay for medication for the rest of their life without formal or informal financial assistance. Lack of means led some patients in the current study to cease treatment, temporarily or permanently, or reduce dosages to make medications last longer. As stated:
The biggest obstacle for me in treating my disease is lack of money to buy medicine. The medicine that I buy from the pharmacy costs about US$7 per box which is too expensive for me. So I have to preserve it to make it last longer; I now only take one pill in the evening or only take it when I don't feel well. But the doctor told me to take it three times a day. If I do that I will finish the medicine really fast. So, by taking one pill in the evening or taking it when the disease causes me problem, I can keep one box for one whole month. (PLWD #17 in Takeo who stopped going to the MSF clinic.)
Travel costs were another factor, affecting patients' ability to go for regular follow-up visits with health care providers. 
